TIGIT as a Therapeutic Target and Marker of T Cell Senescence and Exhaustion

In conclusion, the present study demonstrated that TIGIT is a prominent negative immune regulator involved in immunosenescence. This novel finding is highly significant, as targeting TIGIT might be an effective strategy to improve the immune response and decrease age-related comorbidities.

Source: Fight Aging! - January 24, 2018 Category: Research Authors: Reason Tags: Medicine, Biotech, Research Source Type: blogs